|
||||||
|
 | |
| |
| |
| |
| |
|
Fusion gene ID: 6998 |
FusionGeneSummary for CHD6_DHX58 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: CHD6_DHX58 | Fusion gene ID: 6998 | Hgene | Tgene | Gene symbol | CHD6 | DHX58 | Gene ID | 84181 | 79132 |
| Gene name | chromodomain helicase DNA binding protein 6 | DExH-box helicase 58 | |
| Synonyms | CHD-6|CHD5|RIGB | D11LGP2|D11lgp2e|LGP2|RLR-3 | |
| Cytomap | 20q12 | 17q21.2 | |
| Type of gene | protein-coding | protein-coding | |
| Description | chromodomain-helicase-DNA-binding protein 6ATP-dependent helicase CHD6helicase C-terminal domain- and SNF2 N-terminal domain-containing proteinradiation-induced gene B protein | probable ATP-dependent RNA helicase DHX58DEXH (Asp-Glu-X-His) box polypeptide 58RIG-I-like receptor 3RIG-I-like receptor LGP2RLRRNA helicase LGP2ortholog of mouse D11lgp2probable ATP-dependent helicase LGP2protein D11Lgp2 homolog | |
| Modification date | 20180519 | 20180519 | |
| UniProtAcc | Q8TD26 | Q96C10 | |
| Ensembl transtripts involved in fusion gene | ENST00000373233, ENST00000309279, ENST00000373222, ENST00000480022, | ENST00000251642, | |
| Fusion gene scores | * DoF score | 22 X 14 X 10=3080 | 1 X 1 X 1=1 |
| # samples | 25 | 1 | |
| ** MAII score | log2(25/3080*10)=-3.62293035092018 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(1/1*10)=3.32192809488736 | |
| Context | PubMed: CHD6 [Title/Abstract] AND DHX58 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Functional or gene categories assigned by FusionGDB annotation | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Tgene | DHX58 | GO:0032480 | negative regulation of type I interferon production | 21525357 |
| Tgene | DHX58 | GO:0039536 | negative regulation of RIG-I signaling pathway | 18411269 |
| Tgene | DHX58 | GO:0045088 | regulation of innate immune response | 18411269 |
| Tgene | DHX58 | GO:0045824 | negative regulation of innate immune response | 21525357 |
| Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| TCGA | RV | STAD | TCGA-BR-4357-01A | CHD6 | chr20 | 40043826 | - | DHX58 | chr17 | 40253964 | - |
| * LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| Frame-shift | ENST00000373233 | ENST00000251642 | CHD6 | chr20 | 40043826 | - | DHX58 | chr17 | 40253964 | - |
| intron-3CDS | ENST00000309279 | ENST00000251642 | CHD6 | chr20 | 40043826 | - | DHX58 | chr17 | 40253964 | - |
| intron-3CDS | ENST00000373222 | ENST00000251642 | CHD6 | chr20 | 40043826 | - | DHX58 | chr17 | 40253964 | - |
| intron-3CDS | ENST00000480022 | ENST00000251642 | CHD6 | chr20 | 40043826 | - | DHX58 | chr17 | 40253964 | - |
Top |
FusionProtFeatures for CHD6_DHX58 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| CHD6 | DHX58 |
| Acts as a regulator of DDX58/RIG-I and IFIH1/MDA5mediated antiviral signaling. Cannot initiate antiviral signalingas it lacks the CARD domain required for activating MAVS/IPS1-dependent signaling events. Can have both negative and positiveregulatory functions related to DDX58/RIG-I and IFIH1/MDA5signaling and this role in regulating signaling may be complex andcould probably depend on characteristics of the infecting virus ortarget cells, or both. Its inhibitory action on DDX58/RIG-Isignaling may involve the following mechanisms: competition withDDX58/RIG-I for binding to the viral RNA, binding to DDX58/RIG-Iand inhibiting its dimerization and interaction with MAVS/IPS1,competing with IKBKE in its binding to MAVS/IPS1 therebyinhibiting activation of interferon regulatory factor 3 (IRF3).Its positive regulatory role may involve unwinding or strippingnucleoproteins of viral RNA thereby facilitating their recognitionby DDX58/RIG-I and IFIH1/MDA5. Involved in the innate immuneresponse to various RNA viruses and some DNA viruses such aspoxviruses, and also to the bacterial pathogen Listeriamonocytogenes. Can bind both ssRNA and dsRNA, with a higheraffinity for dsRNA. Shows a preference to 5'-triphosphorylatedRNA, although it can recognize RNA lacking a 5'-triphosphate.{ECO:0000269|PubMed:16116171, ECO:0000269|PubMed:17020950,ECO:0000269|PubMed:17190814, ECO:0000269|PubMed:18411269,ECO:0000269|PubMed:19208642, ECO:0000269|PubMed:19211564,ECO:0000269|PubMed:19278996, ECO:0000269|PubMed:19380577,ECO:0000269|PubMed:21187438, ECO:0000269|PubMed:21525357}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for CHD6_DHX58 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
| * Fusion amino acid sequences. |
| * Fusion transcript sequences (only coding sequence (CDS) region). |
| * Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for CHD6_DHX58 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| CHD6 | AIRE, ARAF, TOLLIP, CHD3, ATXN1L, ZFYVE9, SOX2, HIST3H3, HIST1H2BG, SEC16A, RACGAP1, PAPD5, CDCA5, ESR1, EGFR | DHX58 | AP2B1, AGO2, DICER1, EIF2AK2, STAU1, STAU2, CDKN2AIP, DHX30, EIF6, NKRF, XRN2, APP, USP21 |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for CHD6_DHX58 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for CHD6_DHX58 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Hgene | CHD6 | C0005695 | Bladder Neoplasm | 1 | CTD_human |
| Hgene | CHD6 | C0007138 | Carcinoma, Transitional Cell | 1 | CTD_human |
| Hgene | CHD6 | C0027819 | Neuroblastoma | 1 | CTD_human |
Copyright 2018-Present -The University of Texas Health Science Center at Houston (UTHealth)
|